Одобрена рекомбинантная мультивалентная белковая вакцина против COVID-19 от вариантов XBB USA – Pусский USA – English USA – English Brazil – Português USA – Deutsch Latin America – español
Der rekombinante multivalente COVID-19-Protein-Impfstoff gegen XBB-Varianten von WestVac Biopharma/West China Medical Center, Sichuan University wurde für klinische Versuche zugelassen.
la vacuna proteica contra la COVID-19 multivalente recombinante contra las variantes XBB de WestVac Biopharma/Centro Médico de China Occidental, Sichuan University, se aprobó para ensayos clínicos por la NMPA.
Primeira vacina recombinante multivalente de proteína COVID-19 no mundo contra variantes XBB pela Biopharma/West China Medical Center (Universidade de Sichuan) aprovada para estudos clínicos pela Administração Nacional de Produtos Médicos da China. USA – English USA – English Israel – English India – English Brazil – Português
Food For Health, Wisconsin’s First Medically Tailored Meal Provider Hosts Launch Event
America’s Best Wings: Everything You Need to Know
Health: The Bagnères-de-Bigorre rehabilitation center launches a mobile team of rehabilitation experts
Medical desertification: seduced by Ariège, three interns choose to settle there
Motivated and well-trained first aiders
Caregiver suspended in Castres: “The injury does not disappear with my reintegration”
Seissan hunters are trained in lifesaving gestures
HENDERSON, Nev., May 18, 2023 /PRNewswire/ — Nutrishop, a national retail nutrition franchise specializing in weight loss, wellness, and more, is celebrating 20 years in business....
